首页> 外国专利> COMPOSITION USED FOR ALLEVIATING PREMENSTRUAL SYNDROME-ASSOCIATED SYMPTOM AND PREMENSTRUAL DYSPHORIC DISORDER

COMPOSITION USED FOR ALLEVIATING PREMENSTRUAL SYNDROME-ASSOCIATED SYMPTOM AND PREMENSTRUAL DYSPHORIC DISORDER

机译:用于缓解经期综合征相关症状和经前期营养不良的组合物

摘要

PROBLEM TO BE SOLVED: To provide a novel composition used for alleviating symptoms associated with PMS and PMDD.SOLUTION: The pharmaceutical/nutrient composition of the present invention contains at least 2% (w/w) of phosphatidyl-L-serine or a salt thereof among the whole effective constitution as a first active ingredient and an adequate amount of at least one magnesium having a shape available for an organism as a second active ingredient. The magnesium having a shape available for an organism is a magnesium oxide, a magnesium citrate, a magnesium hydroxide, a magnesium stearate or a magnesium salt of phosphatidyl-L-serine. An excipient for pharmaceutical or nutrient products is further contained. A whole effective composition is administered by intravenous injection or oral administration in plural part therapy. The pharmaceutical/nutrient composition further contains at least 2% (w/w) of phosphatidic acid or a salt thereof among the whole effective constitution, as the first active ingredient.
机译:解决的问题:提供用于减轻与PMS和PMDD有关的症状的新型组合物。解决方案:本发明的药物/营养组合物包含至少2%(w / w)的磷脂酰-L-丝氨酸或盐。在作为第一活性成分的全部有效成分中,它们中的至少一种和适量的至少一种具有对生物体可用形状的镁作为第二活性成分。具有可用于生物体的形状的镁是氧化镁,柠檬酸镁,氢氧化镁,硬脂酸镁或磷脂酰-L-丝氨酸的镁盐。还包含用于药物或营养产品的赋形剂。整体有效的组合物通过静脉内注射或口服给药以多部分疗法给药。在全部有效成分中,药物/营养组合物还包含至少2%(w / w)的磷脂酸或其盐作为第一活性成分。

著录项

  • 公开/公告号JP2014162795A

    专利类型

  • 公开/公告日2014-09-08

    原文格式PDF

  • 申请/专利权人 LIPOGEN LTD;

    申请/专利号JP20140029125

  • 发明设计人 RUTENBERG DAVID;PERRY FAIERWERGER RINA;

    申请日2014-02-19

  • 分类号A61K33/06;A61K31/685;A61K33/08;A61P15/08;A61P25/24;A61P43;A23L1/305;

  • 国家 JP

  • 入库时间 2022-08-21 16:17:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号